Efforts to fight antibiotic-resistant infections — often dubbed superbugs — typically involve strategies of curbing overuse of the antibiotics we already have or finding alternatives.
But what if those pesky superbug infections could simply be prevented in the first place? It's the strategy Gaithersburg-based MedImmune is taking with two of its vaccine candidates aimed at bacterial infections.